首页> 外文会议>International Conference on Environmental Science and Technology >OZONATION OF CETIRIZINE, FEXOFENADINE AND HYDROCHLOROTHIAZIDE: DETERMINATION OF RATE CONSTANTS AND NON-TARGET SCREENING FOR THE IDENTIFICATION OF TRANSFORMATION PRODUCTS
【24h】

OZONATION OF CETIRIZINE, FEXOFENADINE AND HYDROCHLOROTHIAZIDE: DETERMINATION OF RATE CONSTANTS AND NON-TARGET SCREENING FOR THE IDENTIFICATION OF TRANSFORMATION PRODUCTS

机译:氟哌嗪,赤氧苯胺和氢氯噻嗪的臭氧:测定率常数和非靶筛查鉴定转化产物

获取原文

摘要

The removal of pharmaceuticals by ozonation in water and wastewater is currently widely investigated. However, in the last decades, concern about the formation of transformation products (TPs) has been growing. In the present study, the ozonation of three pharmaceuticals considered as emerging contaminants, cetirizine (antihistamine), fexofenadine (antihistamine), and hydrochlorothiazide (diuretic), were investigated: rate constants were determined followed by the characterization of transformation products. Bench-scale ozonation experiments were conducted with the selected pharmaceuticals (0.1 - 0.4 mM) in ultrapure water, and a competition kinetic method was implemented to determine rate constants k_(o3) for the reaction of the target compounds with ozone. All the selected compounds exhibited a high reactivity with ozone with apparent second order rate constants k_(o3,app) ranging from 10~3 and 10~6 M~(-1) s~(-1) in the pH range 3 -12. Transformation products formed during ozonation were detected by a non-target approach using LC-HRMS data (Q-Exactive, Thermo Scientific, San Jose, CA) and SIEVE software (Thermo Scientific, San Jose, CA). Depending on the parent compound, this approach revealed between 6 and 16 transformation products, for which a chemical structure was proposed based on the HRMS and HRMS/MS data. When commercially available, transformation products were confirmed with standards and their formation during ozonation was quantified. Formation yields of these transformation products were then calculated and in the case of hydrochlorothiazide reached 85% for the major ozonation products. Based on the TP structures and known reactivity an ozonation pathway was proposed for the three parent compounds. Finally, environmental relevance of the results was studied with real ozonated wastewater or surface water samples. Fast and efficient removal of the selected parent compounds (> 95%) confirmed the potential of ozonation to remove emerging contaminants. Meanwhile, several ozonation products identified during the bench-scale experiments were confirmed to be present in ozonated effluent samples at ng L~(-1) level.
机译:目前广泛地研究了水和废水中的臭氧化合物去除药物。但是,在过去的几十年中,对转型产品(TPS)的形成令人担忧。在本研究中,研究了三种药物的臭氧化,被认为是新兴污染物,十六胺(抗组胺药),FexofeNaina(抗三明嘌呤)和氢氯噻嗪(利尿剂):测定速率常数,然后进行转化产物的表征。用超纯水中所选药物(0.1-0.4mm)进行的替氏臭氧化实验,并实施竞争动力学方法以确定靶化合物与臭氧的反应率K_(O3)。所有所选化合物与臭氧表现出高反应性,具有表观二阶率常数K_(O3,APP),其在pH范围内的10〜3和10〜6 m〜(1)S〜(-1) 。通过使用LC-HRMS数据(Q-辐射,Thermo Sciencific,San Jose,CA)和筛子软件(Thermo Scientific,San Jose,CA),通过非目标方法检测在臭氧过程中形成的转化产物。取决于母体化合物,该方法在6-16转化产物之间显示,基于HRMS和HRMS / MS数据提出了化学结构。当市售时,用标准证实转化产物并定量臭氧化过程中的形成。然后计算这些转化产物的形成产率,在氢氯噻嗪的情况下达到主要臭氧产品的85%。基于TP结构和已知的反应性,提出了用于三种母体化合物的臭氧途径。最后,使用真正的臭氧废水或地表水样来研究结果的环境相关性。快速高效地除去所选择的母体化合物(> 95%)证实臭氧化以除去新出现的污染物。同时,确认在稳定的实验期间鉴定的几种臭氧化产物存在于Ng L〜(-1)水平的臭氧流出物样品中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号